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Abstract
AIM: To investigate whether a fuzzy logic model could
predict colorectal cancer (CRC) risk engendered by
smoking in hereditary non-polyposis colorectal cancer
(HNPCC) patients.
METHODS: Three hundred and forty HNPCC mismatch
repair (MMR) mutation carriers from the Creighton
University Hereditary Cancer Institute Registry were
selected for modeling. Age-dependent curves were
generated to elucidate the joint effects between gene
mutation (hMLH1 or hMSH2), gender, and smoking
status on the probability of developing CRC.
RESULTS: Smoking significantly increased CRC risk
in male hMSH2 mutation carriers (P < 0.05). hMLH1
mutations augmented CRC risk relative to hMSH2
mutation carriers for males (P < 0.05). Males had a
significantly higher risk of CRC than females for hMLH1
non smokers (P < 0.05), hMLH1 smokers (P < 0.1) and
hMSH2 smokers (P < 0.1). Smoking promoted CRC in a
dose-dependent manner in hMSH2 in males (P < 0.05).
Females with hMSH2 mutations and both sexes with the
hMLH1 groups only demonstrated a smoking effect after
an extensive smoking history (P < 0.05).
CONCLUSION: CRC promotion by smoking in HNPCC
patients is dependent on gene mutation, gender and
age. These data demonstrate that fuzzy modeling

may enable formulation of clinical risk scores, thereby
allowing individualization of CRC prevention strategies.
© 2006 The WJG Press. All rights reserved.
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INTRODUCTION
Accurate risk-stratification is essential for combating the
50 000 yearly deaths from colorectal cancer (CRC) in the
United States[1]. The best-established risk factor is a familial
predisposition to CRC, which is implicated in one-quarter
of all CRC cases[2]. While determining a family history can
be readily accomplished, risk quantification which is critical
for tailoring screening strategies, remains remarkably
imprecise. For instance, even in documented carriers of
CRC predisposing genes, clinical expression can be quite
varied due to modulation by numerous confounding
endogenous and exogenous variables[3,4].
Hereditary non-polyposis colorectal cancer (HNPCC)
represents a case in point. This autosomal dominant
condition is the most common cancer predisposing
syndrome engendering a > 70% lifetime risk of developing
CRC[5]. Furthermore, we have recently demonstrated that
cigarette smoking of a male carrying hMLH1 mutations
(versus hMSH2) increases the hazard of CRC by 1.4-, 1.6and 2.0-fold respectively[6]. However, optimal management
strategies (colonoscopic surveillance versus prophylactic
colectomy) are unclear secondar y to characteristic
phenotypic heterogeneity, i.e. marked variations in age of
onset of cancers[7]. Thus, HNPCC represents an excellent
paradigm to study the gene-environment joint effect
hypothesis.
Incorporating these important findings into clinical
www.wjgnet.com
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practice is hindered by the inability to accurately quantitate
the risk modulation engendered by the joint effects
of genetics and environmental factors. Moreover, the
inadequacy of conventional statistical approaches to
model the complex nature of many of the CRC risk
factors further limits application of these data to patient
management. While landmark studies have explored
the age of CRC diagnosis in HNPCC[8], these estimates
along with others in the literature have not yet factored
in the genetic/environmental influences that determine
the phenotypic heterogeneity. The focus of our study
was on this phenotypic heterogeneity which is of major
importance to clinicians who care for these challenging
patients. We believe that by knowing the genetic and
environmental risk factors, we can individualize more
accurately the risk analysis, which, to our knowledge, has
not been previously reported.
One approach from the engineering literature that has
recently received attention for cancer risk assessment
is fuzzy logic. This powerful modeling technique has
been successfully used for pattern recognition and image
processing and its unique ability to transcend the typical
black or white approaches in standard modeling and to
capture the “shades of gray” has great promise for clinical
medicine[9]. While typical statistical approaches function
well when the data are normally distributed and values
are near the mean, this approach is often inadequate at
the threshold. For instance, a very high prostate specific
antigen (PSA) has excellent predictive ability for prostate
cancer, but the optimal clinical management of a patient
with a mildly elevated value is unclear. Fuzzy logic
overcomes these limitations of conventional statistics
by allowing partial membership function. In our PSA
example, instead of categorizing values as either normal
or abnormal, a fuzzy approach would allow one to place
a value as one quarter in the normal group and threequarters in the abnormal group. Thus, through the creation
of fuzzy sets, elements can have degrees of membership
on a continuum (e.g. a value can be “normal, slightly
elevated, moderately elevated or highly elevated”).
Another unique attribute of fuzzy modeling is that,
unlike traditional models, it does not require prior
knowledge of the system being modeled. It is a “modelfree” form in which natural rules are developed from the
data rather than imposing rules on the modeling system.
The result of this “model-free” system is still a conversion
from inputs to outputs, similar to traditional algorithms[10].
Another strength of fuzzy modeling lies in its ability
to model data points that may be outside of traditional
inclusion boundaries and thus allowing accurate modeling
with less data.
Past reports have demonstrated that fuzzy modeling
can improve perfor mance characteristics of tumor
markers over conventional applications[11-13]. Our previous
work with conventional statistical approaches (COX
proportional hazard modeling) indicated that tobacco
use, gender and mutated gene play an important role in
phenotypic presentation of CRC progression in HNPCC
patients as a group, but lack the ability to predict an
individual risk of CRC (e.g. not sensitive to dose effects
or interactions of factors). We, therefore, explored the
www.wjgnet.com
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Figure 1 Overview of fuzzy methodology.

ability of fuzzy modeling to predict CRC risk in germline
mutation carriers in these individual HNPCC patients by
factoring the gene type, gender and tobacco use status in
the present study.

MATERIALS AND METHODS
Database
The Hereditary Cancer Center at Creighton University
is one of the oldest and largest registries for diverse
hereditary cancer syndrome, containing information on
over 200 000 individuals of whom approximately 600
are verified MMR mutation carriers (Lynch Database).
The database contains patient and family information,
surveillance and treatment information as well as gene
mutations and lifestyle data. The inclusion criteria were
HNPCC as documented by either a MMR ger mline
mutation positivity or clinical HNPCC from a patient who
had a family member with a documented MMR mutation.
For example, if the patient has HNPCC and his mother
has a documented hMSH2 mutation, we would consider
the patient to have an hMSH2 mutation. Tobacco data
were obtained by self-report and family report or by
abstraction from medical records. A patient was classified
as a tobacco user if he/she reported ever regularly using (or
was reported to have ever regularly used) cigarettes, cigars,
a pipe, tobacco chew, or snuff. Five hundred and ninety-six
mutation carriers were identified from 62 HNPCC families.
For this analysis we only focused on cigarette smokers.
Of these, 340 (60.4%) had information on tobacco use
and were included in our study (158 nonsmokers and
182 smokers). In a further analysis, 271 patients (113 of
182 smokers and 158 nonsmokers) with a more detailed
smoking history including calculated pack-years were
selected.
Modeling
The entire modeling procedure was performed using
the MatLab Fuzzy Toolbox (Matlab, Version 6.1-Release
13, Natick, MA). Figure 1 provides an over view of
the basic fuzzy modeling algorithm. The data (either
categorical or continuous) were inputted into the program
and a clustering algorithm led to the development of
membership functions. The fuzzy clustering method
used produces descriptions of each of the input vectors
as belonging to one (or more) fuzzy sets with a specific
membership in each of the sets. The inclusion of a
continuous variable (pack-years and age) produces noncatagorical (aka, fuzzy) memberships. Rules are then
developed from these membership functions which
successfully produce a mapping from the input space to
the output space as previously described[10]. Furthermore,
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Figure 2 Scattergram demonstrating the
probability of developing CRC (cumulative
lifetime risk) for each subject based on
smoking status, ▲= Smokers, □ = NonSmokers. Data are divided by gene mutation
and sex with (A) hMLH1: Female, (B)
hMLH1: Male, (C) hMSH2: Female and (D)
hMSH2: Male (P < 0.05).
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these rules represent fuzzy relationships between the
variables, even if the variables themselves are categorical.
The refinement of these rules is accomplished using the
Adaptive Neural Fuzzy Inference System (ANFIS; 16)
which acts as a feedback loop to further refine the rules
until they are optimized to give the best fit to the data.
Overfitting of the model to the data is not exclusively
addressed. However, the clustering methods (subtractive
clustering) employed in the modeling scheme tend to
partition the data space in such a manner as to maximize
the cluster density while simultaneously maximizing the
separation of the clusters which would limit overfitting.
This modeling technique was applied to the patients
selected from the Lynch database with gene mutation, sex,
smoking status and age as the input and risk of developing
colorectal cancer as the output. In a second study, the
effect of pack years was added as an additional input.
In this case, dividing a group of smokers with a given
mutation, sex and age further by smoke years made the
numbers in each group quite small. We therefore used the
data as the training set and a theoretical set of conditions
as the input to generate the model output. The models
produced a cumulative risk of CRC that ranged between 0
and 1. Age and pack years were fuzzified in the program.
Statistical analysis
Results are presented either as a scattergram of the actual
model output for each patient in the database (Figures 2-4)
or as an output of the model given a set of theoretical
conditions (Figure 5). The statistical procedures used
followed the methods described by Steel and Torrie[14]. The
data for each cohort were paired and compared using a
Kolmagrov-Smirnov (KS) 2-sample test. The KS test was
considered to be conservative and useful when hypothesis
about discrete distributions was tested. The test is
motivated by the need to compare 2 independent samples
and the null hypothesis is that each sample originates from

identical distributions (i.e., the data are from the same
population). Critical values for the KS test are inversely
proportional to the square root of the total number of
observations. The nature of our data dictated that the
critical values were computed using unequal populations (n1
≠ n2). Furthermore, the nature of the data and results only
required a comparison of this type. Other analyses, such
as a test of trend or analysis of variance, were not deemed
beneficial.

RESULTS
Smoking status
The influence of genetic mutation combined with sex,
smoking status and age is demonstrated in Figure 2.
There was a clear impact of cigarette smoking on the ageadjusted risk of developing CRC for all conditions tested
(gene mutated and gender).
When a male patient with the hMSH2 gene mutation
car rier smokes, he markedly increased his risk of
developing CRC by up to 2.4-fold at the age of 78 (Figure
2D, P < 0.05). In the case of a mutation in the hMLH1
gene, smoking increased the risk of CRC at the maximal
age tested by approximately 1.3-fold for males when
compared to non-smokers (Figure 2B). Females with the
hMLH1 mutation showed a 1.3-fold increased risk of
developing CRC and female smokers with the hMSH2
mutation had a 1.4-fold greater risk of developing CRC
when compared to their non-smoking age-matched
controls (Figures 2A and 2C).
Gene
The model output was then reexamined as a function of
the genetic mutation (Figure 3). For males, patients with
a hMLH1 mutation had either a 2.5- or a 1.3-fold greater
risk of developing CRC than those with a hMSH2 for nonsmokers and smokers respectively (Figures 3B and 3D, P <
www.wjgnet.com
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Figure 3 Scattergram demonstrating the
probability of developing CRC (cumulative
lifetime risk) for each subject based on
genetic mutation, ◊ = hMLH1, ● = hMSH2.
Data are divided by sex and smoking
status with (A) Female: non-smokers (P <
0.001), (B) Female: smokers (P < 0.001),
(C) Male: non-smokers (P < 0.001) and (D)
Male: smokers (P < 0.05). The P values
show the probability failing to reject the
null hypothesis that the data originate from
identical populations, indicating that the
curves are different.
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Figure 4 Scattergram demonstrating the
probability of developing CRC (cumulative
lifetime risk) for each subject based on
gender, △ = female, ▼=male. Data are
divided by gene mutation and smoking
status with (A) hMLH1: non-smokers, (B)
hMLH1: smokers (P < 0.1), (C) hMSH2:
non-smokers (P > 0.05) and (D) hMSH2:
smokers (P < 0.1). The P values show
the probability of failing to reject the null
hypothesis that the data originate from
identical populations, indicating that the
curves are different.
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0.05). The difference was greater for the non-smokers than
the smokers because subjects with hMSH2 who smoke
increased their rate of CRC greater than the non-smokers.
Female non-smokers with the hMLH1 mutation showed a
1.5-fold increase in CRC risk as compared to the hMSH2
subjects, whereas it was 1.4-fold higher for smokers.

mutations (Figure 4A, P < 0.05) and smokers (1.6-fold)
(Figure 4B, P < 0.1). Smoking males with the hMSH2
mutation also had a greater risk of CRC than hMSH2
mutation harboring females by 1.6-fold (Figure 4D, P
< 0.01), but the gender effect dissipated in nonsmokers
(Figure 4C, P > 0.05).

Gender
Figure 4 demonstrates that males had a greater risk of
developing CRC than females when compared to an
equivalent age, gene mutation and smoking status. Males
had a significantly higher risk of CRC than females
(1.5-fold) for non-smoking subjects with the hMLH1

Smoking dose response
A subset of the data which had an estimate of pack years
was then modeled to determine if there was an association
between lifetime quantities of cigarettes smoked and risk
of CRC. The mean consumption was 24-pack years for
patients who smoked cigarettes. Figure 5 demonstrates the

www.wjgnet.com
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risk of developing CRC as a function of pack years. For
female smokers with a hMLH1 mutation (Figure 5A), the
CRC risk was only increased after 30-pack years (P < 0.01),
whereas for males (Figure 5B) the risk did not significantly
increase until 40-pack years (P < 0.05). Similarly, females
with a hMSH2 (Figure 5C) only demonstrated a smoking
effect at 40-pack years (P < 0.01). Conversely, males with
a hMSH2 mutation (Figure 5D) had an increased risk of
developing CRC in a dose-dependent fashion in response to
the number of cigarettes smoked over their lifetime (P < 0.01).

DISCUSSION
We have demonstrated herein that by using a fuzzy
modeling approach, we could quantitatively predict the
effect of environmental factors on risk of developing CRC
in subjects who harbor a germline mutation for HNPCC.
Importantly, we could calculate estimates for the impact
of modifiable risk factors (i.e. smoking) on the occurrence
of CRC in these high-risk patients and individualize the
risk estimates by accounting for other major factors on the
phenotypic variability in HNPCC patients: the mutated
gene (hMLH1 versus hMSH2) and gender. Thus, we
believe that these results may be a useful tool in patient
counseling by providing concrete estimates of the impact
of risk factor modification.
Our observations regarding the gene-environmental
joint effects were made possible by the remarkable
resource represented by the Creighton Hereditary Cancer
Center Registry. Although it is one of the oldest and
largest HNPCC registries in the world, a conventional
statistical approach to this dataset is not powerful enough
to detect the gene-environment joint effect and the doseresponse of smoking and CRC[15], because the relatively
small subgroup size markedly reduces statistical power
in conventional (e.g. Cox proportional hazard modeling)
statistical approaches. One approach to mitigate these
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concerns is to increase the size of groups (e.g. to evaluate
effect of age by increasing 40-59, 60-79, etc). However,
such large groups have clear disadvantages. For instance,
a 41-year old individual and a 58-year old individual may
be quite biologically/ clinically different and yet are in the
same stratum. Fuzzy modeling enables partial membership
functions. For instance, a 43-year old individual may
be considered to be 80% in the 40-50 group and 20%
belonging to the 30-39 category, whereas a 59-year old
individual may be 65% in the 50-59 group and 35%
within the 60-70 group. Thus, fuzzy modeling allows us to
account for the heterogeneity, i.e., “shades of gray” that is
a hallmark of clinical medicine.
There are several lines of evidence that support the
biological validity of our findings with fuzzy modeling.
Cigarette use is an important risk factor for CRC, and
12% of all CRC deaths are attributed to smoking[16]. Many
studies indicate that cigarette smoking can increase the
incidence of colon cancers by approximately two fold,
however there are numerous contradictory reports[17-19].
T hese discordant data have been clarified by the
demonstration that cigarette smoking may selectively
increase the risk for DNA mismatch repair[20]. This may
be related to the observation that smoking preferentially
promotes microsatellite unstable (MSI-high) tumors.
The molecular pathway is also seen in Lynch syndrome
tumors[19]. For instance, Yang et al[21] have recently reported
that cigarette smoking increases the risk of developing
MMR-deficient tumors by 3.1-fold. Additionally, Slattery
et al[22] demonstrated that smoking 20 cigarettes per day
increases the risk of MMR-deficient tumors by 1.6-fold in
men (95% CI = 1.0-2.5) and 2.2-fold in women (95% CI
= 1.4-3.5). Furthermore, they have documented a dosedependent relationship between smoking and colorectal
cancer [22] . T his dose-dependence underscores the
plausibility of the cigarette-induced CRC risk. While we
were able to discern an effect of smoking in our previous
www.wjgnet.com
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study in HNPCC- cigarette smoking data set with Cox
proportional hazard modeling, the lack of dose response
raises concerns about the validity of the findings [15] .
Using fuzzy modeling we demonstrated a much clearer
relationship. For instance, our dose response model
predicts that female smokers with a hMLH1 mutation
who have at least 30-pack years of smoking will have an
increase in the lifetime risk of CRC by 2.2- fold. A 3.3-fold
increase is seen for females with an hMSH2 mutation after
40 pack years. Males with a hMSH2 mutation have a more
linear increase in their lifetime risk of developing CRC as a
function of pack years.
This ability to quantitate an individual’s risk is of
paramount clinical importance due to the variability in
CRC presentation that is characteristic of HNPCC. For
instance, some members of a kindred may develop CRC
at age 25 and 65 while other members may never develop
it. Given this heterogeneity, “one size fits all” approach
to management (the current state of the art) is clearly
inadequate. Indeed, previous attempts to determine
the optimal cancer prevention strategy (prophylactic
colectomy versus colonoscopic surveillance) have failed
to conclusively demonstrate the superiority of any single
approach [7]. Even determining the best colonoscopic
intervals is unclear. While our group recommends annual
colonoscopy starting at age 25 [23] , a large number of
negative examinations are expensive and have potential
complications and may lead to patient complacency.
Increasing surveillance intervals is fraught with danger
given both the rapid adenoma to carcinoma transition
and also the flat nature of the lesions, leading to a higher
possibility of lesions being missed on colonoscopy[23]. The
consequences of inadequate screening are underscored
by the report of Jarvinen and colleagues[24], who noted
that over a 15-year observation period, 8.4% of HNPCC
patients who did not undergo screening would die of CRC
whereas none of those who were in a screening program
can succumb to this malignancy. Indeed, in mutation
positive subjects, development of CRC occur in 42%
of the non-screened but only 18% in patients receiving
screening (P < 0.02) [24] . Thus, implementation and
adherence of a screening regimen are critical in protecting
these high-risk patients against CRC.
It needs to be emphasized that the ability of fuzzy
modeling to quantitate risk may be of considerable
importance in counseling patients. For instance, being able
to tell patients that their risk of CRC more than doubles
with smoking may be more tangible than stating that
smoking is detrimental to ones health, thereby providing
a greater impetus for behavior modification. By accurately
delineating risk, patients will be able to concretely identify
modifiable risk factors and ascertain the impact of their
lifestyle changes, thus providing positive reinforcement.
In this regard, Halpert and colleagues[25] noted that genetic
testing of HNPCC patients may have a profound effect
upon motivation for cancer prevention strategies such as
colonoscopy. Improved adherence with CRC screening
regimens from genetic testing and counseling is also
documented by Hadley and associates[26]. The malleability
of CRC prevention behaviors in HNPCC patients is
further highlighted by Adams and colleagues [27] who
www.wjgnet.com
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documented the effect of socio-economic considerations
on age of resection of CRC in HNPCC patients. Thus, we
believe that added information obtained by fuzzy modeling
may have a dramatic effect on patient behavior and thus
outcomes. There are previous demonstrations of the
efficacy of fuzzy logic to cancer risk stratification. Fuzzy
logic has been used with impressive success to improve the
sensitivity of tumor markers in diagnosing cancer[11-13].
There are several limitations of this report that need
to be acknowledged. As any modeling, the accuracy of
the results is dependent on quality of the data inputted.
Many of our patients did not have data to quantitate packyears. Bias in the database due to patient/family report is
possible (e.g. having cancer may influence recollection of
tobacco use history). Since tobacco use is not a “standard”
risk-factor for CRC, we do not think this will impact
the results. With smoking, there is always concern about
confounding from “competing causes of mortality”[28].
However we have recently shown that this effect is
negligible for the smoking-CRC effect[29]. Finally, while our
modeling accurately reflects our database, the algorithms
need to be validated in other databases.
In conclusion, a fuzzy modeling approach represents
a promising means of predicting the phenotypic
heterogeneity in colorectal cancer presentation in HNPCC
mutation carriers. The methodology may be an important
tool in unraveling the gene-environment joint effects
in hereditary cancer syndromes. Furthermore, this may
serve as the basis for future paradigms that determine
individualized cancer prevention strategies in subjects
harboring an inherited risk.
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